CD8B and neoplasm: Experiments shown in Fig 2A demonstrate that that CD8 T‐cell depletion with an anti‐CD8β mAb completely abolished 17D‐induced tumor control in the directly injected (Fig 2B) and in the contralateral tumor nodules (Fig 2C), and lead to reduced overall survival (Fig 2D).